121 related articles for article (PubMed ID: 29249192)
1. DNA damage response-initiated cytokine secretion in bone marrow stromal cells promotes chemoresistance of myeloma cells.
Tang H; Shu M; Dai B; Xu L; Dong B; Gao G; Chen X
Leuk Lymphoma; 2018 Sep; 59(9):2220-2226. PubMed ID: 29249192
[TBL] [Abstract][Full Text] [Related]
2. Blockade of SDF-1/CXCR4 reduces adhesion-mediated chemoresistance of multiple myeloma cells via interacting with interleukin-6.
Liu Y; Liang HM; Lv YQ; Tang SM; Cheng P
J Cell Physiol; 2019 Nov; 234(11):19702-19714. PubMed ID: 30953364
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.
Nefedova Y; Landowski TH; Dalton WS
Leukemia; 2003 Jun; 17(6):1175-82. PubMed ID: 12764386
[TBL] [Abstract][Full Text] [Related]
4. TLR5 activation by flagellin induces doxorubicin resistance via interleukin-6 (IL-6) expression in two multiple myeloma cells.
Cho HY; Lee SW
Cell Immunol; 2014; 289(1-2):27-35. PubMed ID: 24709011
[TBL] [Abstract][Full Text] [Related]
5. The ATM kinase inhibitor KU-55933 provides neuroprotection against hydrogen peroxide-induced cell damage via a γH2AX/p-p53/caspase-3-independent mechanism: Inhibition of calpain and cathepsin D.
Chwastek J; Jantas D; Lasoń W
Int J Biochem Cell Biol; 2017 Jun; 87():38-53. PubMed ID: 28341201
[TBL] [Abstract][Full Text] [Related]
6. Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion.
Uchiyama H; Barut BA; Mohrbacher AF; Chauhan D; Anderson KC
Blood; 1993 Dec; 82(12):3712-20. PubMed ID: 8260708
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes multiple myeloma resistance through the JAK2/STAT3 pathway.
Huang J; Huang LQ; He HS; Yan J; Huang C; Wang R; Guan Y; Huang DP
Life Sci; 2020 Sep; 257():118088. PubMed ID: 32663573
[TBL] [Abstract][Full Text] [Related]
8. [Molecular mechanism of Doxorubicin resistance in multiple myeloma cell line].
Lu YY; Xiao CR; Chen HY; Huang X; Hu JS; Lu QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1336-40. PubMed ID: 25338584
[TBL] [Abstract][Full Text] [Related]
9. [Regulation of miRNA-15a/-16 expression on the drug resistance of myeloma cells].
Zang MR; Li F; An G; Xie ZQ; Li CH; Yu Z; Xu Y; Qiu LG; Hao M
Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1100-3. PubMed ID: 22781767
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment.
Hayashi T; Hideshima T; Nguyen AN; Munoz O; Podar K; Hamasaki M; Ishitsuka K; Yasui H; Richardson P; Chakravarty S; Murphy A; Chauhan D; Higgins LS; Anderson KC
Clin Cancer Res; 2004 Nov; 10(22):7540-6. PubMed ID: 15569984
[TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma-derived exosomes inhibit osteoblastic differentiation and improve IL-6 secretion of BMSCs from multiple myeloma.
Liu Z; Liu H; Li Y; Shao Q; Chen J; Song J; Fu R
J Investig Med; 2020 Jan; 68(1):45-51. PubMed ID: 31784427
[TBL] [Abstract][Full Text] [Related]
12. Notoginsenoside R1 counteracts mesenchymal stem cell-evoked oncogenesis and doxorubicin resistance in osteosarcoma cells by blocking IL-6 secretion-induced JAK2/STAT3 signaling.
Lu M; Xie K; Lu X; Lu L; Shi Y; Tang Y
Invest New Drugs; 2021 Apr; 39(2):416-425. PubMed ID: 33128383
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapy.
Ramachandran IR; Condamine T; Lin C; Herlihy SE; Garfall A; Vogl DT; Gabrilovich DI; Nefedova Y
Cancer Lett; 2016 Feb; 371(1):117-24. PubMed ID: 26639197
[TBL] [Abstract][Full Text] [Related]
14. The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma.
Ren Z; Lantermans H; Kuil A; Kraan W; Arenzana-Seisdedos F; Kersten MJ; Spaargaren M; Pals ST
J Hematol Oncol; 2021 Jan; 14(1):11. PubMed ID: 33436043
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression.
Hao M; Zhang L; An G; Meng H; Han Y; Xie Z; Xu Y; Li C; Yu Z; Chang H; Qiu L
Leuk Lymphoma; 2011 Sep; 52(9):1787-94. PubMed ID: 21534877
[TBL] [Abstract][Full Text] [Related]
16. [The interaction of vascular endothelial growth factor and interleukin-6 in multiple myeloma].
Zhang L; Chen SL; Chen WM; Liu JW
Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):85-8. PubMed ID: 15840215
[TBL] [Abstract][Full Text] [Related]
17. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
[TBL] [Abstract][Full Text] [Related]
18. The bone marrow stromal microenvironment influences myeloma therapeutic response in vitro.
Cheung WC; Van Ness B
Leukemia; 2001 Feb; 15(2):264-71. PubMed ID: 11236942
[TBL] [Abstract][Full Text] [Related]
19. [Effect of mesenchymal stem cells on multiple myeloma cells growth and inhibition of bortezomib induced cell apoptosis].
Hao M; Xie ZQ; Han YJ; An G; Meng HX; Huang J; Li CH; Zou DH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2010 Oct; 31(10):680-3. PubMed ID: 21223719
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of APE1/Ref-1 and its regulation on IL-6 and IL-8 in bone marrow stromal cells of multiple myeloma.
Xie JY; Li MX; Xiang DB; Mou JH; Qing Y; Zeng LL; Yang ZZ; Guan W; Wang D
Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):385-93. PubMed ID: 21030352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]